COVID-19變種病毒加護病房病危個案中醫介入治療病例報告

Traditional Chinese Medicine as interventional treatment to care a critically ill case of COVID-19 variant virus in intensive care unit -A Case Report

蘇郁婷(Yu-Ting Su)；龔彥穎(Yen-Ying Kung)；陳方佩(Fang-Pey Chen)；張凱惟(Kei-Wei Chang)

COVID-19 ； Omicron ； 病危 ； 中西醫 ； COVID-19 ； Omicron ； Critical illness ； traditional Chinese medicine and Western Medicine

北台灣中醫醫學雜誌

15卷1期（2023 / 03 / 01）

33 - 51

繁體中文;英文

2022年COVID-19變種病毒Omicron開始於臺灣各地爆發並迅速流行，多數感染者為無症狀或症狀輕微，但對於年長者卻是一大威脅，往往迅速轉成重症，甚至是危重症，死亡率極高。本病例為高齡92歲女性，罹患COVID-19變種病毒後，約3天內轉成重症進入加護病房，經西醫救治後仍面臨瀕死狀態並發布病危通知，家屬尋求中醫介入治療後，病情逐漸穩定並順利出院返家休養，藉由本病例之中西醫結合治療過程與用藥思維，提供中醫師研究與參考。

In 2022, the Omicron variant of COVID-19 began to break out and spread rapidly in various parts of Taiwan. Most infected people were asymptomatic or had mild symptoms, while it was a big threat to the elderly. The condition of elderly infected people tended to deteriorate rapidly and even became critically ill rapidly; besides, the mortality rate was extremely high. This case was a 92-year-old woman. She was transferred to the intensive care unit within about 3 days after suffering from the COVID-19 variant virus. Even received Western medicine treatment continuing, she was still facing a dying state and a critical illness notice was issued. After her family members sought interventional treatment from traditional Chinese medicine, her condition gradually stabilized. Finally, she discharged from the hospital successfully and returned home to recuperate. This case study provided the treatment process and medication thinking of integrated traditional Chinese medicine and Western medicine for Chinese medical physicians.

1. Arora, S.(2022).Literature Review of Omicron: A Grim Reality Amidst COVID-19.Microorganisms,10(2)
2. Cai, S., Q,Wang, X.,Sang, M., Y,Xu, F,Liu, G, X.(2015).Efficacy Theory" may help to explain characteristic advantages of traditional Chinese medicines.Chine. J. Chinese Materia Med,40(17),3435-3443.
3. Cao, Y.(2022).BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.Nature,608(7923),593-602.
4. Chen, L.(2011).Synergistic activity of baicalein with ribavirin against influenza A (H1N1) virus infections in cell culture and in mice.Antiviral Res,91(3),314-320.
5. Du, H.K.,Song, F.C.,Zhou, X.,Li, H.,Zhang, J.P.(2009).Effect of amygdlin on type Ⅰ and Ⅲcollagen expression in rats with pulmonary fibrosis induced by bleomycin.J Chinese PLA Postgrad Med Sch,30,712-717.
6. Fogo, A.S.(2009).Tormentic acid reduces vascular smooth muscle cell proliferation and survival.Eur J Pharmacol,615(1-3),50-54.
7. Gao, S.M.(2018).Traditional uses, phytochemistry, pharmacology and toxicology of Codonopsis: A review.J Ethnopharmacol,219,50-70.
8. He, X.Y.(2020).Amygdalin - A pharmacological and toxicological review.J Ethnopharmacol,254,112717.
9. Kario, K.(2020).COVID-19 and hypertension-evidence and practical management: Guidance from the HOPE Asia Network.J Clin Hypertens (Greenwich),22(7),1109-1119.
10. Keske, S.(2022).Duration of infectious shedding of SARS-CoV-2 Omicron variant and its relation with symptoms.Clin Microbiol Infect
11. Kim, S.O.(2015).Saikosaponin a, an active compound of Radix Bupleuri, attenuates inflammation in hypertrophied 3T3-L1 adipocytes via ERK/NF-kappaB signaling pathways.Int J Mol Med,35(4),1126-1132.
12. Lee, J.C.(2007).Stimulating effects on mouse splenocytes of glycoproteins from the herbal medicine Atractylodes macrocephala Koidz.Phytomedicine,14(6),390-395.
13. Li, Y.,Yang, X.W(2014).Neweudesmane-type sesquiterpenoids from the processed rhizomes of Atractylodes macrocephala.Journal of Asian Natural Products Research,16,123-128.
14. Liao, P.(2020).Baicalin alleviates deoxynivalenol-induced intestinal inflammation and oxidative stress damage by inhibiting NF-kappaB and increasing mTOR signaling pathways in piglets.Food Chem Toxicol,140,111326.
15. Lu, P.-H.(2022).Jing Si Herbal Drink as a prospective adjunctive therapy for COVID-19 treatment: Molecular evidence and mechanisms.Pharmacological Research - Modern Chinese Medicine,2
16. Lu, Y.C.,Chen, H.H.,Ko, C.H.(2003).The mechanism of honokiol-induced and magnolol-induced inhibition on muscle contraction and Ca2+ mobilization in rat uterus.Naunyn-Schmiedeberg,s Arch. Pharmacol,368(4),262-269.
17. Ren, J.L.,Zhang, A.H.,Wang, X.J.(2020).Traditional Chinese medicine for COVID-19 treatment.Pharmacol Res,155,104743.
18. Shang, C.(2021).Beneficial effects of cinnamon and its extracts in the management of cardiovascular diseases and diabetes.Food Funct,12(24),12194-12220.
19. Song, H.P.(2015).Atractylodes macrocephala Koidz stimulates intestinal epithelial cell migration through a polyamine dependent mechanism.J Ethnopharmacol,159,23-35.
20. Su, H.(2020).,未出版
21. Tu, Y.(2022).Extracts of Poria cocos improve functional dyspepsia via regulating braingut peptides, immunity and repairing of gastrointestinal mucosa.Phytomedicine,95,153875.
22. Vabret, N.(2020).Immunology of COVID-19: Current State of the Science.Immunity,52(6),910-941.
23. Wang, K.T.(2010).Gastroprotective activity of atractylenolide III from Atractylodes ovata on ethanol-induced gastric ulcer in vitro and in vivo.J Pharm Pharmacol,62(3),381-388.
24. Wang, N.(2018).Molecular mechanism of Poria cocos combined with oxaliplatin on the inhibition of epithelial-mesenchymal transition in gastric cancer cells.Biomed Pharmacother,102,865-873.
25. Wu, S.N.,Chen, C.C.,Li, H.F.(2002).Stimulation of the BKCa channel in cultured smooth muscle cells of human trachea by magnolol.Thorax,57(1),67-74.
26. Wu, X.N.(2011).Protective effect of a polyphenolic rich extract from Magnolia officinalis bark on influenza virus-induced pneumonia in mice.J Ethnopharmacol,134(1),191-194.
27. Xiong, Y.J.,Li, X.J.,Mulati, Shen, S.K.(2000).Influence on intestinal tract of Codonopsis clematidea and Codonopsis pilosula.Pharmacol. Clin. Chin. Mater. Med,16(2),15.
28. Yang, NY,T.W,Duan, JA(2010).Antithrombotic flavonoids from the faeces of Trogopterus xanthipes.Nat Prod Res,24(19),1843-1849.
29. Yang, NY,T.W,Duan, JA,Guo, JM,Cao, LL(2009).Four new fatty acid esters from the feces of Trogopterus xanthipes.Lipids,44(9),849-853.
30. 張金堅,許辰陽,賴昭智,許文峰,廖思涵,林世斌,趙從賢,任小萱,彭思敏,陳秀熙(2020)。新冠肺炎 （COVID-19） 的免疫學探討。臺灣醫界，63(10)，13-26。
31. 衛生福利部疾病管制署，確診個案解隔條件修訂摘要 https://www.cdc.gov.tw/File/Get/WmeUy8jIY_0t1bBp_cSKHg.